RBM24 and colorectal carcinoma: Given our results showing that RBM24 expression was positively associated with PTEN expression and negatively influenced the PI3K/Akt signalling pathway, CRC cells overexpressing RBM24 were subjected to treatment with PTEN inhibitor SF1670.